- Home
- SKYH vs MIST Comparison
SKYH vs MIST Comparison
Compare SKYH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYH | MIST |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 176.3M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SKYH | MIST |
|---|---|---|
| Price | $9.95 | $1.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $13.83 | $8.50 |
| AVG Volume (30 Days) | 120.3K | ★ 1.4M |
| Earning Date | 03-19-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $77.13 | $1,653.36 |
| Revenue Next Year | $82.38 | $12.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.22 | $0.63 |
| 52 Week High | $14.20 | $3.06 |
Technical Indicators
Market Signals| Indicator | SKYH | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 64.83 | 23.55 |
| Support Level | $9.55 | N/A |
| Resistance Level | $10.47 | $1.79 |
| Average True Range (ATR) | 0.40 | 0.11 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 87.83 | 0.00 |
Price Performance
Historical ComparisonAbout SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).